CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Sophiris Bio Inc.  (SPHS)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

SPHS's Revenue Year on Year Growth by Quarter and Year

Sophiris Bio's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
SPHS Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 0.03 - 0.01
III Quarter September - - - 0.01
II Quarter June - - 0.01 0.01
I Quarter March 0.05 0.01 0.01 0.02
FY   0.05 0.04 0.02 0.05

Financial Statements
Sophiris Bio's first quarter 2017 Revenue $ 0.05 millions SPHS's Income Statement
Sophiris Bio's first quarter 2016 Revenue $ 0.01 millions Quarterly SPHS's Income Statement
SPHS's Growth by Division See SPHS's Growth by Segment

SPHS Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - 0 % -
I Quarter March 410 % 0 % -50 % -
FY   - 100 % -60 % -



SPHS Revenue Growth Comment
Sophiris Bio Inc. achieved in the first quarter, above Company average Revenue surge of 410% year on year, to $ 0.05 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Revenue growth. While Sophiris Bio Inc.' s Revenue doubling of 410% ranks overall at the positon no. 59 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #13
S&P 500 #59
Revenue Y/Y Growth Statistics
High Average Low
920 % 125.32 % -66.67 %
(Mar 31 2017)   (Dec 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SPHS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SPHS's Competitors
Revenue Growth for Sophiris Bio's Suppliers
Revenue Growth for SPHS's Customers

You may also want to know
SPHS's Annual Growth Rates SPHS's Profitability Ratios SPHS's Asset Turnover Ratio SPHS's Dividend Growth
SPHS's Roe SPHS's Valuation Ratios SPHS's Financial Strength Ratios SPHS's Dividend Payout Ratio
SPHS's Roa SPHS's Inventory Turnover Ratio SPHS's Growth Rates SPHS's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Biocept Inc  660.30 %$ 660.298 millions
Geovax Labs, Inc.  521.29 %$ 521.292 millions
Cytomx Therapeutics, Inc.  424.20 %$ 424.202 millions
Sientra, Inc.  409.11 %$ 409.109 millions
Sorrento Therapeutics, Inc.  393.32 %$ 393.320 millions
Bluebird Bio, Inc.  355.77 %$ 355.771 millions
Agenus Inc  352.36 %$ 352.365 millions
Protalix Biotherapeutics, Inc.  325.48 %$ 325.479 millions
Lifestyle Medical Network, Inc.  319.44 %$ 319.438 millions
Orexigen Therapeutics, Inc.  280.39 %$ 280.389 millions
Intellia Therapeutics, Inc.  249.75 %$ 249.747 millions
Biolargo, Inc.  230.06 %$ 230.060 millions
Corbus Pharmaceuticals Holdings, Inc.  226.20 %$ 226.199 millions
Exact Sciences Corp  226.01 %$ 226.006 millions
Accelerate Diagnostics, Inc.  225.15 %$ 225.153 millions
American Cryostem Corp  205.95 %$ 205.946 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com